Gain Insight into Upcoming Treatments for Multiple Sclerosis With New Disease and Therapy Review
Posted on: Thursday, 17 May 2007, 09:00 CDT
Research and Markets (http://www.researchandmarkets.com/reports/c57078) has announced the addition of Disease and Therapy Review: Multiple Sclerosis to their offering.
The Multiple Sclerosis Disease and Therapy Review provides incidence and prevalence numbers and percentages for major countries worldwide, and an overview of treatments, including beta-interferons, Copaxone, Novantrone, and Tysabri. Dosing and drug storage and preparation information is provided, along with the annual cost for each therapy. General information is included on annual sales of Avonex, Copaxone, and Rebif.
Disease and Therapy Reviews were developed to provide a basic understanding of the key facts about a disease and market in a quick, easy-to-read format. These reports are prepared by a senior market research team. Each Disease and Therapy Review provides a concise analysis of the most important information about a particular disease, its treatment, and the market opportunities. Reports begin with an overview of the condition, and also contain tables that summarize the available worldwide incidence and prevalence data for the condition, a review of current diagnosis strategies and treatment options, general information about the market size, and information about important market trends. The data contained in these reports comes from key industry secondary data sources, such as the Timely Data Resources Incidence and Prevalence Database, and Langes Current Medical Diagnosis and Treatment. This information is supplemented by reviews of analyst reports, company reports, and medical websites. Sources and references are provided.
I. OVERVIEW
II. INCIDENCE AND PREVALENCE
Incidence Table: (US, UK, Spain, Worldwide)
Prevalence Table: (US, Canada, UK, France, Germany, Italy, Spain, Japan, China, India, Worldwide)
III. TREATMENT
Beta-Interferon Products
Copaxone
Novantrone
Tysabri
Steroid Treatment
IV. DOSING
V. TREATMENT COSTS
VI. MARKET SIZE
VII. COMMENTS
VIII. REFERENCES/RESOURCES
For more information visit http://www.researchandmarkets.com/reports/c57078
Source: Business Wire
Related Articles
- Get a Deep Insight into The World Alzheimer's Disease Market (Incidence, Treatments, Key Companies, Pipeline and Trends)
- Disease and Therapy Review: Obesity Was Developed to Provide a Basic Understanding of the Key Facts About Obesity and Market in a Quick Easy to Read Format
- Diagnosis: Treatments: Leading Products - Disease and Therapy Review: Alzheimers Disease
- Most Important Information: Disease and Therapy Review - Bipolar Disorder
- Disease and Therapy Review: Current Diagnosis Strategies and Treatment Options for Insomnia
- New Disease and Therapy Review on Urinary Incontinence Features Chapters on Diagnosis, Dosing and Treatment Costs and Treatment
- In the New Edition of 'Disease and Therapy Review', Diagnosis of Neuropathic Pain is Covered As Well As Information on Treatment Options Approved By the FDA for the Treatment of Neuropathic Pain
- The Systemic Lupus Erythematosus Disease And Therapy Review Provides Incidence And Prevalence Numbers And Percentages For Major Countries Worldwide
- Disease & Therapy Review (DTR) Executive Market Summaries Provide Accurate Market Data Across a Range of Therapeutic Areas
 |
 |
User Comments (0)
RSS Feeds